Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combined CRAFITY score and α-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving anti-programmed death-1 blockade-based immunotherapy.
Hsu WF, Lai HC, Chen CK, Wang HW, Chuang PH, Tsai MH, Chen SH, Chu CS, Su WP, Chou JW, Kao JT, Chen HY, Chuang SC, Tsai TY, Hsiao WD, Huang GT, Peng CY. Hsu WF, et al. Among authors: chuang ph. Am J Cancer Res. 2023 Feb 15;13(2):654-668. eCollection 2023. Am J Cancer Res. 2023. PMID: 36895987 Free PMC article.
Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients.
Lee MH, Huang CF, Lai HC, Lin CY, Dai CY, Liu CJ, Wang JH, Huang JF, Su WP, Yang HC, Kee KM, Yeh ML, Chuang PH, Hsu SJ, Huang CI, Kao JT, Chen CC, Chen SH, Jeng WJ, Yang HI, Yuan Y, Lu SN, Sheen IS, Liu CH, Peng CY, Kao JH, Yu ML, Chuang WL, Chen CJ. Lee MH, et al. Among authors: chuang ph, chuang wl. Sci Rep. 2017 Jun 16;7(1):3718. doi: 10.1038/s41598-017-02313-y. Sci Rep. 2017. PMID: 28623331 Free PMC article.
Alpha-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving immune checkpoint inhibitors with or without tyrosine kinase inhibitors or locoregional therapies.
Hsu WF, Wang HW, Chen CK, Lai HC, Chuang PH, Tsai MH, Su WP, Chen HY, Chu CS, Chou JW, Chen SH, Tsai TY, Hsiao WD, Lin CC, Huang GT, Lin JT, Peng CY. Hsu WF, et al. Among authors: chuang ph. Am J Cancer Res. 2021 Dec 15;11(12):6173-6187. eCollection 2021. Am J Cancer Res. 2021. PMID: 35018250 Free PMC article.
123 results